A study using data shared by 20 life insurance companies suggests that adults aged between 35 and 44 died at twice the expected rate last summer in the US.
- EXPLOSIVE: Here’s what was uncovered in Hunter Biden’s iCloud Hack
- MAJOR PEER REVIEWED STUDY: Moderna Vaccine Increases Myocarditis Risk By 44 Times In Young Adults
- MUST READ: High Level International Bankers Simulate The Collapse Of Global Financial System
- BIG STORY: Wuhan Lab Isolated Monkeypox Strain In 2020
- EXPLOSIVE: Ukraine Biolabs Used Fever Carrying Mosquitoes To Spark Dengue Pandemic In Cuba
According to data from 20 of the top 21 life insurance firms in the United States, the number of death claims for working-age adults under group life insurance plans increased significantly throughout the course of the last summer and fall.
In July, August, and September 2021, the number of death claims for people aged 35 to 44 was 100% greater than anticipated, according to a survey by the Society of Actuaries, which examined 2.3 million death claims made to life insurance companies.
The COVID-19 pandemic, which lasted for 24 months from April 2020 to March 2022, was the focus of the study (pdf below) on death claims made under group life insurance plans. To establish a baseline for the anticipated mortality, the researchers analysed information from the three years prior to the pandemic.
During the two pandemic years, COVID-19 contributed to some of the excess deaths among those over the age of 34, whereas the situation was reversed for those under the age of 34. According to the data, there were more excess non-COVID fatalities among people under the age of 34 than COVID-related deaths.
Subscribe to GreatGameIndia
Deaths in the 25 to 34 age group during the third quarter of last year were 78 percent higher than anticipated, and deaths in the 45 to 54 age group were 80 percent higher than anticipated. For adults aged 55 to 64, excess mortality was 53 percent higher than the baseline.
The 20 participating life insurance companies were questioned by the Society of Actuaries (SOA) regarding how they identify the cause of death for the purposes of recording claims. Eight of the 18 respondents said they go above and beyond and consult with family members, the medical examiner, and other sources in an effort to identify the true cause of death. Of the 18 who responded, 17 said they list COVID-19 as the cause of death if it appears anywhere on the death certificate.
One life insurance provider said that it only listed COVID-19 as the cause of death when the primary cause of death could be established on a death certificate.
The report also mentions that throughout the two years under investigation, white-collar workers experienced the highest excess mortality rate. There were 23% more deaths than anticipated in the group, which includes accountants, attorneys, computer programmers, and most other office-based occupations.
Scott Davison, CEO of the Indianapolis-based life insurance company OneAmerica, who stated in a virtual press conference on December 30, 2021 that his company and the life insurance industry as a whole was seeing a 40% increase in deaths among people ages 18 to 64, was the first to bring attention to the sharp rise in deaths among working-age people.
At the time, Davison claimed that these death rates were the highest in the history of the life insurance industry and that an increase in mortality of just 10% would result in a “three-sigma” event, a calamity occurring only once every 200 years.
OneAmerica is one of the twenty companies that provided information for the SOA report. The others are Principal Financial, MetLife, Anthem, The Hartford, Lincoln Financial Group, Aflac, Anthem, and The Hartford.
The rate of deaths among young people, according to Edward Dowd, a hedge fund manager who has been researching excess mortality over the previous few months, is disturbing. The Biden administration’s need for COVID-19 vaccines, he noted, coincided with a peak in the number of excess deaths, and companies hurried to comply.
“Temporally, in that three-month period, the change was such that, there was something that occurred,” he said. “Well, we all know what occurred in August, September, and October. It was Biden’s mandates on Sept. 9, and a lot of corporations anticipating those mandates.”
On September 9, 2021, COVID-19 vaccinations for federal employees and healthcare personnel working in facilities recognised by Medicare and Medicaid were made mandatory by President Joe Biden. On the same day, the president directed OSHA, the federal agency responsible for occupational safety and health, to establish a nationwide vaccination requirement for privately owned companies with 100 or more employees.
The OSHA mandate was overturned by the U.S. Supreme Court in January, but the rule for healthcare employees was left in effect.
The largest vaccination campaign in global history is the one to immunise the bulk of the populace against COVID-19.
About 90% of Americans aged 18 or older had received at least the first dose of one of the COVID-19 vaccines as of August 31; 77% had received both the first and second doses.
Excess mortality must constantly be studied, according to Dr. Robert Malone, a medical professional and research scientist who is credited with developing the mRNA technology used in vaccinations.
He said, “Excess mortality should be a signal, a trigger.” “When we see excess mortality like that—basically if you’re running a clinical trial and you see this kind of excess mortality, you stop the trial. And you investigate the cause before you proceed. And if you’re marketing a drug, generally, with this kind of data, you stop the distribution of the drug until you have sorted it out.”
Malone brought up what he refers to as the “classic example” of thalidomide, a morning sickness drug that was effective in treating morning sickness but had severe side effects on the unborn children who were given it to a small number of pregnant women in the United States in the late 1950s and early 1960s.
The drug manufacturer had pushed the U.S. Food and Drug Administration to approve the medication, but the FDA declined because of the reported deformities.
Another example, he continued, is cholesterol treatment. Cardiologists, he said, were convinced in the 1990s that cholesterol was the “bad actor” and that heart disease rates would decrease if it could be reduced.
“So they came out with some really good drugs for dropping cholesterol, and they ran the trials,” he said, “and it clearly showed that they were effective in dropping cholesterol in humans, to a remarkable level, very, very effective. And everything was on track for approval, at those doses. And then the all-cause mortality data started coming in.”
“And paradoxically, people were dying, but they weren’t dying of heart attacks. Their heart attack death rate was better. They were committing suicide, because when you pull cholesterol out of the brain, you trigger depression.”
Malone had academic positions as a pathology professor at the University of California-Davis and the University of Maryland, where he also had a lab.
Specifically on the Vaccine Adverse Event Reporting System (VAERS), where the government has only taken into account deaths that occur within 2 to 3 weeks of vaccination, he claimed that the CDC and FDA have been in denial about what all-cause mortality data show in the case of COVID-19. This is because they believe that the mRNA doesn’t stay in the body for longer.
The mRNA persists in the body for at least 60 days, according to studies, which he claims demonstrates that this is false.
According to Malone, the government is supposed to conduct studies on all-cause mortality for any medicine or vaccine for at least a year after approval. However, he claims that there is no evidence that they have done this for the COVID-19 vaccines.
“The FDA basically threw away the rulebook, and let Fauci do whatever he wanted to do,” he says.
The Society of Actuaries released the following statement in lieu of immediate availability for comment on the findings on excess mortality over the 24-month period:
“The Society of Actuaries Research Institute’s January and August 2022 reports regarding U.S. Group Life COVID-19 mortality explore the impact of COVID-19 on the group life insurance sector and does not address or consider vaccine status. The research does not validate any claims made that suggest a causal relationship between COVID-19 vaccines and mortality. Any claims implying such a relationship are a misrepresentation of the data presented in the report and are not reflective of the Society of Actuaries Research Institute’s views.”
Requests for comment regarding whether the CDC is researching all-cause mortality data for COVID-19 vaccine safety signals were not immediately returned by the CDC.
Read the report given below: